All In Biotech

Drug Trial Radar · NCT01984684

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

A Phase 3, Multicenter, Randomized, Double-blind, Active Controlled Study to Evaluate the Efficacy + Safety of IV + Oral Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Last checked: Nov 20, 2026Latest source record: Nov 17, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 850 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

850

Actual

Start

May 2014

Primary completion

Dec 2015

Study completion Jan 2016

Sponsor

Lead sponsor
Melinta Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Nov 15, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effects of Delafloxacin versus Vancomycin plus Aztreonam in the treatment of patients with acute bacterial skin and soft tissue infections.

Conditions

  • Skin and Subcutaneous Tissue Bacterial Infections
  • Skin Structures and Soft Tissue Infections

Interventions

  • delafloxacinDrug

  • vancomycinDrug

  • aztreonamDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response of ≥20% Reduction in Lesion Erythema Area Compared to Baseline at 48 to 72 Hours After Initiation of Treatment as Determined by Digital Measurements of the Leading Edge.Time frame: 48 to 72 hrs after starting treatment

Locations

94 sites in 16 countries. Site status is shown where the registry gives one.

  • Melinta 303 Study Site

    Mobile, Alabama

  • Melinta 303 Study Site

    Montgomery, Alabama

  • Melinta 303 Study Site

    Anaheim, California

  • Melinta 303 Study Site

    Chula Vista, California

  • Melinta 303 Study Site

    La Mesa, California

  • Melinta 303 Study Site

    Long Beach, California

  • Melinta 303 Study Site

    Modesto, California

  • Melinta 303 Study Site

    Oceanside, California

  • Melinta 303 Study Site

    San Diego, California

  • Melinta 303 Study Site

    Stockton, California

  • Melinta 303 Study Site

    Torrance, California

  • Melinta 303 Study Site

    DeLand, Florida

  • Melinta 303 Study Site

    Orlando, Florida

  • Melinta 303 Study Site

    Columbus, Georgia

  • Melinta 303 Study Site

    Savannah, Georgia

  • Melinta 303 Study Site

    Eunice, Louisiana

  • Melinta 303 Study Site

    Springfield, Massachusetts

  • Melinta 303 Study Site

    Minneapolis, Minnesota

  • Melinta 303 Study Site

    Butte, Montana

  • Melinta 303 Study Site

    Lincoln, Nebraska

  • Melinta 303 Study Site

    Las Vegas, Nevada

  • Melinta 303 Study Site

    Somers Point, New Jersey

  • Melinta 303 Study Site

    Teaneck, New Jersey

  • Melinta 303 Study Site

    Columbus, Ohio

  • Melinta 303 Study Site

    Toledo, Ohio

  • Melinta 303 Study Site

    Rapid City, South Dakota

  • Melinta 303 Study Site

    Jackson, Tennessee

  • Melinta 303 Study Site

    Smyrna, Tennessee

  • Melinta 303 Study Site

    Channelview, Texas

  • Melinta 303 Study Site

    Houston, Texas

  • Melinta 303 Study Site

    San Antonio, Texas

  • Melinta 303 Study Site

    Córdoba, Argentina

  • Melinta 303 Study Site

    Santa Fe, Argentina

  • Melinta 303 Study Site

    La Plata, Buenos Aires, Argentina

  • Melinta 303 Study Site

    Rosario, Santa Fe Province, Argentina

  • Melinta 303 Study Site

    São Paulo, Brazil

  • Melinta 303 Study Site

    Salvador, Estado de Bahia, Brazil

  • Melinta 303 Study Site

    Belo Horizonte, Minas Gerais, Brazil

  • Melinta 303 Study Site

    Lavras, Minas Gerais, Brazil

  • Melinta 303 Study Site

    Passo Fundo, Rio Grande do Sul, Brazil

Showing 40 of 94 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.